Wahab Mohamed Abdel, Hamed Hosam, Salah Tarek, Elsarraf Waleed, Elshobary Mohamed, Sultan Ahmed Mohamed, Shehta Ahmed, Fathy Omar, Ezzat Helmy, Yassen Amr, Elmorshedi Mohamed, Elsaadany Mohamed, Shiha Usama
Mohamed Abdel Wahab, Hosam Hamed, Tarek Salah, Ahmed Mohamed Sultan, Ahmed Shehta, Omar Fathy, Mohamed Elsaadany, Gatrointestinal Surgery and Liver Transplantation Unit, Gastrointestinal Surgical Center, Mansoura University, Daqahlia 35516, Egypt.
World J Gastroenterol. 2014 Oct 7;20(37):13607-14. doi: 10.3748/wjg.v20.i37.13607.
We report our experience with potential donors for living donor liver transplantation (LDLT), which is the first report from an area where there is no legalized deceased donation program. This is a single center retrospective analysis of potential living donors (n = 1004) between May 2004 and December 2012. This report focuses on the analysis of causes, duration, cost, and various implications of donor exclusion (n = 792). Most of the transplant candidates (82.3%) had an experience with more than one excluded donor (median = 3). Some recipients travelled abroad for a deceased donor transplant (n = 12) and some died before finding a suitable donor (n = 14). The evaluation of an excluded donor is a time-consuming process (median = 3 d, range 1 d to 47 d). It is also a costly process with a median cost of approximately 70 USD (range 35 USD to 885 USD). From these results, living donor exclusion has negative implications on the patients and transplant program with ethical dilemmas and an economic impact. Many strategies are adopted by other centers to expand the donor pool; however, they are not all applicable in our locality. We conclude that an active legalized deceased donor transplantation program is necessary to overcome the shortage of available liver grafts in Egypt.
我们报告了我们在活体肝移植(LDLT)潜在供体方面的经验,这是来自一个尚未实施合法脑死亡器官捐赠项目地区的首份报告。这是一项对2004年5月至2012年12月期间1004名潜在活体供体进行的单中心回顾性分析。本报告重点分析了供体被排除(792例)的原因、持续时间、成本及各种影响。大多数移植受者(82.3%)有过不止一位供体被排除的经历(中位数=3)。一些受者前往国外接受脑死亡供体移植(12例),一些受者在找到合适供体前死亡(14例)。对被排除供体的评估是一个耗时的过程(中位数=3天,范围1天至47天)。这也是一个成本高昂的过程,中位数成本约为70美元(范围35美元至885美元)。从这些结果来看,活体供体被排除对患者和移植项目有负面影响,存在伦理困境和经济影响。其他中心采取了许多策略来扩大供体库;然而,并非所有策略都适用于我们当地。我们得出结论,要克服埃及可用肝脏供体短缺的问题,实施积极的合法脑死亡供体移植项目是必要的。